Clinical Trials Update: April 4, 2008
Rheumatoid Arthritis
Multiple Sclerosis
Schizophrenia and Schizoaffective Disorders
|
E-mail this article
Subscribe to news
Printer friendly version
|
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Rheumatoid Arthritis
If you are of legal age of consent, have active rheumatoid arthritis based on American College of Rheumatology criteria, and have been taking methotrexate for at least 12 weeks, you may qualify for this study.
The research site is in Las Vegas, Nev.
More information
Please see http://www.centerwatch.com/patient/studies/cat132.html 
.
-----
Multiple Sclerosis
If you are between 18 and 55 and have a confirmed diagnosis of relapsing/remitting multiple sclerosis, you may qualify for this study. The research site is in Oklahoma City, Okla.
More information
Please see http://www.centerwatch.com/patient/studies/cat102.html .
-----
Schizophrenia and Schizoaffective Disorders
If you are aged 18 to 75, have been diagnosed with schizophrenia for more than a year, have had an increase in symptoms in the last two months, and are otherwise in good physical health, you may qualify for this study.
The research site is in Norristown, Penn.
More information
Please see http://www.centerwatch.com/patient/studies/cat135.html .
-----
Copyright 2008 Thomson CenterWatch . All rights reserved.
Copyright © 2008 ScoutNews, LLC. All rights reserved. 
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.